About Tagomics
Tagomics is a company based in Birmingham (United Kingdom) founded in 2020. Tagomics has raised $8.45 million across 2 funding rounds from investors including Agilent, Mercia and Calculus Capital. Tagomics offers products and services including Interlace. Tagomics operates in a competitive market with competitors including Guardant Health, Foundation Medicine, ArcherDX, Natera and Strand Life Sciences, among others.
- Headquarter Birmingham, United Kingdom
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Tagomics Ltd
- Date of Incorporation 22 Jul, 2020
- Jurisdiction COVENTRY, ENGLAND
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$8.45 M (USD)
in 2 rounds
-
Latest Funding Round
$1.17 M (USD), Grant
Jun 10, 2025
-
Investors
Agilent
& 8 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Tagomics
Tagomics offers a comprehensive portfolio of products and services, including Interlace.
Enables identification of disease-associated DNA biomarkers from various samples.
People of Tagomics
Unlock access to complete
Unlock access to complete
Funding Insights of Tagomics
Tagomics has successfully raised a total of $8.45M across 2 strategic funding rounds. The most recent funding activity was a Grant round of $1.17 million completed in June 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Tagomics
Tagomics has secured backing from 9 investors, including venture fund and institutional investors. Prominent investors backing the company include Agilent, Mercia and Calculus Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
UK venture capital investments are managed by Calculus Capital.
|
Locked | Locked | Locked | |
|
Health tech startups are invested in by Illumina Ventures.
|
Locked | Locked | Locked | |
|
Deep tech venture capital firm investing in European and global startups.
|
Locked | Locked | Locked |
Investor details for Tagomics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Tagomics
Investment portfolio details for Tagomics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Tagomics
Detailed financials for Tagomics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Tagomics Comparisons
Peer comparison for Tagomics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Tagomics
Tagomics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guardant Health, Foundation Medicine, ArcherDX, Natera and Strand Life Sciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Digital sequencing technology for cancer detection is developed.
|
|
| Locked | Locked | Locked |
Genomics-based diagnostic tests for cancer are provided.
|
|
| Locked | Locked | Locked |
Molecular cancer diagnostic products are developed using patented AMP technology.
|
|
| Locked | Locked | Locked |
Developer of cell-free DNA testing for oncology, women’s health, and organ health
|
|
| Locked | Locked | Locked |
Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery
|
|
| Locked | Locked | Locked |
Health risks are identified through online genetic and diagnostic testing.
|
Detailed competitors of Tagomics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Tagomics
Complete news archive for Tagomics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Tagomics
Tagomics was founded in 2020 and raised its 1st funding round 4 years after it was founded.
Tagomics is headquartered in Birmingham, United Kingdom. It is registered at Birmingham, England, United Kingdom.
Tagomics is a funded company, having raised a total of $8.45M across 2 funding rounds to date.
Tagomics was founded in 2020 and is headquartered in Birmingham, United Kingdom. Operations are centered in the biotechnology sector, where a genomic-based cancer diagnostic platform is developed. Non-invasive blood tests are utilized to capture unmodified genome locations, with analysis focused on changes that occur during cancer progression. Services are provided to support early detection in oncology diagnostics.
Tagomics's top competitors include Guardant Health, Strand Life Sciences and Foundation Medicine.
Tagomics offers Interlace.
Tagomics has 9 investors. Key investors include Agilent, Mercia, Calculus Capital, UK Research and Innovation, and Illumina Ventures.